540204 EIKO

Eiko Lifesciences Share Price

₹58.50 -0.62 (-1.05%)

23 Nov, 2024 18:35

SIP TrendupStart SIP in EIKO

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -1.8%
  • Over 3 Month + 0.31%
  • Over 6 Month + 16.44%
  • Over 1 Year -5.05%
SIP Lightning

Smart Investing Starts Here Start SIP with Eiko Lifesciences for Steady Growth!

Invest Now

Eiko Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Eiko Lifesciences Financials

Eiko Lifesciences Technicals

EMA & SMA

Current Price
₹58.50
-0.62 (-1.05%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹62.28
  • 50 Day
  • ₹61.83
  • 100 Day
  • ₹60.51
  • 200 Day
  • ₹59.45

Resistance and Support

59.21 Pivot Speed
  • R3 63.32
  • R2 62.11
  • R1 60.42
  • S1 57.52
  • S2 56.31
  • S3 54.62

What's your outlook on Eiko Lifesciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Eiko Lifesciences has an operating revenue of Rs. 33.50 Cr. on a trailing 12-month basis. An annual revenue growth of 47% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 80 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Eiko Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-25 Rights issue of Equity Shares
2024-10-19 Quarterly Results
2024-08-13 Quarterly Results
2024-05-13 Audited Results
2024-02-08 Quarterly Results

Eiko Lifesciences F&O

Eiko Lifesciences Shareholding Pattern

24.4%
49.05%
26.55%

About Eiko Lifesciences

  • NSE Symbol
  • EIKO
  • BSE Symbol
  • 540204
  • ISIN
  • INE666Q01016

Similar Stocks to Eiko Lifesciences

Eiko Lifesciences FAQs

Eiko Lifesciences share price is ₹58 As on 23 November, 2024 | 18:21

The Market Cap of Eiko Lifesciences is ₹58.4 Cr As on 23 November, 2024 | 18:21

The P/E ratio of Eiko Lifesciences is 52.8 As on 23 November, 2024 | 18:21

The PB ratio of Eiko Lifesciences is 1.1 As on 23 November, 2024 | 18:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23